Search Results - "Lachi, Ginevra"
-
1
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases
Published in Pharmacological research (01-10-2024)“…Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic disorders characterized by dysregulated immune response and…”
Get full text
Journal Article -
2
Tu1726 GPBAR1 AGONISM AND SIMULTANEOUS RORΓT INVERSE AGONISM AS A NOVEL PROMISING THERAPY FOR THE TREATMENT OF IBD
Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)Get full text
Journal Article -
3
Sa1563 BAR502 AS A PROMISING THERAPY FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS: INSIGHTS FROM MURINE MODEL STUDIES
Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)Get full text
Journal Article -
4
774 FXR AGONISM AND PRIMARY BILE ACIDS: DRIVERS OF IMMUNEESCAPE IN INTESTINAL GASTRIC CANCER (GC)
Published in Gastroenterology (New York, N.Y. 1943) (18-05-2024)Get full text
Journal Article -
5
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis
Published in Biochemical pharmacology (01-05-2024)“…[Display omitted] The leukemia inhibitory factor (LIF) is member of interleukin (IL)-6 family of cytokines involved immune regulation, morphogenesis and…”
Get full text
Journal Article -
6